Cargando…
[(18)F]FDG Positron Emission Tomography within Two Weeks of Starting Erlotinib Therapy Can Predict Response in Non-Small Cell Lung Cancer Patients
PURPOSE: The aim of this prospective study was to evaluate whether [(18)F]FDG-PET/CT, performed within two weeks of starting erlotinib therapy can predict tumor response defined by RECIST 1.1 criteria after 8 weeks of treatment in patients with inoperable (stage IIIA to IV) non-small cell lung cance...
Autores principales: | Hachemi, Mammar, Couturier, Olivier, Vervueren, Laurent, Fosse, Pacôme, Lacœuille, Franck, Urban, Thierry, Hureaux, José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914822/ https://www.ncbi.nlm.nih.gov/pubmed/24505298 http://dx.doi.org/10.1371/journal.pone.0087629 |
Ejemplares similares
-
For avid glucose tumors, the SUV peak is the most reliable parameter for [(18)F]FDG-PET/CT quantification, regardless of acquisition time
por: Sher, Avigaëlle, et al.
Publicado: (2016) -
Doxycycline treatment in dialysis related amyloidosis: discrepancy between antalgic effect and inflammation, studied with FDG-positron emission tomography: a case report
por: Piccoli, Giorgina Barbara, et al.
Publicado: (2017) -
(18)F-FDG Positron Emission Tomography in Multifocal Pyomyositis
por: Harisankar, C. N. B., et al.
Publicado: (2012) -
18F-FDG 18F-FDG Positron Emission Tomography Imaging of Cortical Reorganization in Spinal Trauma
por: Chopra, Jigyasa, et al.
Publicado: (2022) -
Uptake of (18)FDG by a Hepatic Adenoma on Positron Emission Tomography
por: Stephenson, J. A., et al.
Publicado: (2011)